Education
About Us
Working with TipRanks
Follow Us
NeoGenomics (NEO)
NASDAQ:NEO
Earnings Data
Report Date
Feb 25, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.04Last Year’s EPS
0.04Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a strong performance in the clinical segment, driven by volume and revenue growth, successful acquisitions, and favorable legal outcomes. However, challenges remain in nonclinical revenue, particularly in pharma, which are expected to persist into 2026.Company Guidance
Record Clinical Volumes and Revenue Growth
Total clinical revenue increased by 18% from prior year, driven by a 15% increase in test volumes and a 4% increase in AUP. NGS revenues grew by 24% over prior year and accounted for 33% of total clinical revenue.
Successful Pathline Acquisition
The acquisition of Pathline is expected to offer faster turnaround times in the Northeast region, the #3 cancer care market in the U.S., and is anticipated to be accretive to profitability beginning in 2026.
Favorable Court Ruling for RaDaR ST
A favorable court ruling paved the way for the full clinical launch of the RaDaR ST MRD assay, with a robust launch planned for Q1 of 2026.
PanTracer LBx Launch
PanTracer LBx, a noninvasive blood-based test, was launched after incorporating learnings from an evaluation assessment program, with expectations of commercial availability and growth in 2026.
NEO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NEO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 28, 2025 | $10.16 | $9.92 | -2.36% |
Jul 29, 2025 | $6.46 | $5.25 | -18.73% |
Apr 29, 2025 | $9.97 | $6.58 | -34.00% |
Feb 18, 2025 | $14.42 | $12.40 | -14.01% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does NeoGenomics (NEO) report earnings?
NeoGenomics (NEO) is schdueled to report earning on Feb 25, 2026, TBA (Confirmed).
What is NeoGenomics (NEO) earnings time?
NeoGenomics (NEO) earnings time is at Feb 25, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NEO EPS forecast?
NEO EPS forecast for the fiscal quarter 2025 (Q4) is 0.04.
